Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Investigating endoplasmic reticulum and mitochondrial stress in a rodent model of the neurodevelopmental risk of schizophrenia

FY 2025-26

Summary
Schizophrenia is a serious mental illness that affects about 1% of people worldwide. It causes symptoms like hallucinations, delusions, and problems with cognition (such as issues with memory, attention, and executive function). Past research on schizophrenia has focused mostly on changes to the brain’s dopamine system, but newer studies are suggesting that stress inside cells as well as inflammation in the body and brain may also play an important role. However, we still do not fully understand how cellular stress and inflammation relate to the cognitive problems seen in schizophrenia. This project will study these connections using a well-known rat model of schizophrenia risk called the MAM model. MAM model rats show brain and behavior changes similar to those found in humans with schizophrenia. In this study, we will test MAM model rats with tasks that measure attention and cognitive flexibility. After testing, we will examine their brains and blood to look for signs of stress in different types of brain cells as well as inflammation in their brains and bodies. We expect that MAM rats will perform worse in the cognitive tests than healthy rats and will also show higher levels of inflammation and cell stress, especially in specific brain areas important for cognitive processes. By comparing cognitive performance with these biological markers, we aim to learn how these processes interact in schizophrenia. Our goal is to build a clearer picture of the changes occurring in brain cells that contribute to cognitive symptoms in schizophrenia. This knowledge may help guide the development of future treatments aimed at improving cognitive issues for people with the disorder.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572872
Name
Chiella James
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating endoplasmic reticulum and mitochondrial stress in a rodent model of the neurodevelopmental risk of schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Er Stress; Inflammation; Mitochondria; Rodent Model; Schizophrenia
Abstract
Schizophrenia is a serious mental illness that affects about 1% of people worldwide. It causes symptoms like hallucinations, delusions, and problems with cognition (such as issues with memory, attention, and executive function). Past research on schizophrenia has focused mostly on changes to the brain’s dopamine system, but newer studies are suggesting that stress inside cells as well as inflammation in the body and brain may also play an important role. However, we still do not fully understand how cellular stress and inflammation relate to the cognitive problems seen in schizophrenia. This project will study these connections using a well-known rat model of schizophrenia risk called the MAM model. MAM model rats show brain and behavior changes similar to those found in humans with schizophrenia. In this study, we will test MAM model rats with tasks that measure attention and cognitive flexibility. After testing, we will examine their brains and blood to look for signs of stress in different types of brain cells as well as inflammation in their brains and bodies. We expect that MAM rats will perform worse in the cognitive tests than healthy rats and will also show higher levels of inflammation and cell stress, especially in specific brain areas important for cognitive processes. By comparing cognitive performance with these biological markers, we aim to learn how these processes interact in schizophrenia. Our goal is to build a clearer picture of the changes occurring in brain cells that contribute to cognitive symptoms in schizophrenia. This knowledge may help guide the development of future treatments aimed at improving cognitive issues for people with the disorder.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chiella, James
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~